Clinical trial Recruiting at 2 sites Interventional Ages 18 to 42 Women only

Comparing letrozole and artificial cycles for preparing the uterus in women with irregular periods

Official title: Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy for Endometrial Preparation in Women With Irregular Menstrual Cycles: A Randomized Controlled Trial

Run by Mỹ Đức Hospital · NCT06372119 · Data updated 2026-11-12

This study is testing if using letrozole to prepare the uterus can help women with irregular periods have more successful pregnancies after freezing and transferring embryos compared to using an artificial hormone cycle.

More Embryo Transfer trials

Quick facts

Study typeInterventional
Ages18 Years to 42 Years
SexWomen only
Enrollment790 (estimated)
SponsorMỹ Đức Hospital
Academic / other
Locations2 sites (Ho Chi Minh City, Ho Chi Minh City and 1 other locations)
StatusRecruiting
StartedApril 22, 2024
Main results expectedApril 2026
Study endsApril 2026
Registry record updatedSeptember 25, 2025
Trial IDNCT06372119 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 to 42 with irregular menstrual cycles who require endometrial preparation for embryo transfer.

Probably not a fit

Patients with certain endometrial or uterine abnormalities, or those with a history of recurrent pregnancy loss or implantation failure, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a letrozole-stimulated cycle strategy versus an artificial cycle strategy for endometrial preparation in women experiencing irregular menstrual cycles. Participants will be randomly assigned to receive either letrozole to stimulate follicular development or an artificial cycle regimen using estradiol and progesterone. The primary goal is to determine if the letrozole approach leads to a higher live birth rate after frozen embryo transfer compared to the artificial cycle method. The study addresses a significant challenge in assisted reproduction technology by exploring a more natural preparation method for the endometrium.

Why it matters

Potential benefit: If successful, this study could improve live birth rates for women with irregular menstrual cycles undergoing frozen embryo transfer.

How similar studies have gone: Previous studies have shown promise in using letrozole for endometrial preparation, suggesting that this approach may be effective, though it is still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 - 42.
* Irregular menstrual cycle (\< 21 days or \> 35 days or \< 8 cycles/years).
* Indicated for endometrial preparation.
* Transfer of only one blastocyst.
* Not participating in any other trials.

Exclusion Criteria:

* Allergy to letrozole or Ovitrelle or oral estradiol valerate or micronized progesterone
* Having embryos from either oocyte donation or PGT (pre-implantation genetics testings) cycles.
* Ovarian cysts that are unrelated to the oocyte pick-up.
* Confirmed diagnosis with recurrent pregnancy loss (RPL) according to ESHRE guideline 2023, recurrent implantation failure (RIF) according to ESHRE 2023 good practice recommendations.
* Endometrial abnormalities include endometrial hyperplasia, intrauterine adhesions, endometrial polyp, and chronic endometritis.
* Uterine abnormalities include leiomyomas L0, L1, or L2 (according to FIGO 2011); adenomyosis (according to MUSA 2022); congenital uterine abnormalities, include didelphus, arcuate, unicornuate, bicornuate, septate (according to ASRM 2021).
* Untreated hydrosalpinx.

Where it's running

  • My Duc Hospital
    Ho Chi Minh City, Ho Chi Minh City, Vietnam
    Recruiting
  • My Duc Phu Nhuan Hospital
    Ho Chi Minh City, Ho Chi Minh City, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Lan TN Vuong, Assoc. Prof. — University of Medicine and Pharmacy at Ho Chi Minh City
  • Study coordinator: Nam T Nguyen, MD.
  • Email: bsnam.nt@myduchospital.vn
  • Phone: +84354120209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.